Published in Biochemistry on November 16, 1976
DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev (1998) 6.96
Dynamic interaction between a Drosophila transcription factor and RNA polymerase II. Mol Cell Biol (1989) 2.97
Genetic interaction between transcription elongation factor TFIIS and RNA polymerase II. Mol Cell Biol (1992) 2.59
Role of the mammalian transcription factors IIF, IIS, and IIX during elongation by RNA polymerase II. Mol Cell Biol (1991) 2.45
Elongation factor-dependent transcript shortening by template-engaged RNA polymerase II. J Biol Chem (1992) 2.36
Transcription elongation factor SII. Bioessays (2000) 2.20
The RNA polymerase II general elongation factors. Trends Biochem Sci (1996) 1.99
Initiation and regulation of simian virus 40 early transcription in vitro. J Virol (1982) 1.77
Positive regulation of general transcription factor SIII by a tailed ubiquitin homolog. Proc Natl Acad Sci U S A (1995) 1.77
The RNA polymerase II elongation complex. Factor-dependent transcription elongation involves nascent RNA cleavage. J Biol Chem (1992) 1.69
Mechanism and regulation of transcriptional elongation by RNA polymerase II. Curr Opin Cell Biol (1999) 1.55
Evidence that transcript cleavage is essential for RNA polymerase II transcription and cell viability. Mol Cell (2010) 1.55
Identification of a 3'-->5' exonuclease activity associated with human RNA polymerase II. Proc Natl Acad Sci U S A (1993) 1.46
Proteins that bind to RNA polymerase II are required for accurate initiation of transcription at the adenovirus 2 major late promoter. EMBO J (1986) 1.36
Dissection of transcription factor TFIIF functional domains required for initiation and elongation. Proc Natl Acad Sci U S A (1995) 1.32
In vitro characterization of mutant yeast RNA polymerase II with reduced binding for elongation factor TFIIS. Proc Natl Acad Sci U S A (1996) 1.27
RNA polymerase II elongation complex. Elongation complexes purified using an anti-RNA antibody do not contain initiation factor alpha. J Biol Chem (1991) 1.23
Molecular cloning of an essential subunit of RNA polymerase II elongation factor SIII. Proc Natl Acad Sci U S A (1994) 1.15
Transcription elongation factor SII interacts with a domain of the large subunit of human RNA polymerase II. Mol Cell Biol (1988) 1.11
Purification of transcription cofactor complex CRSP. Proc Natl Acad Sci U S A (1999) 1.07
TATA-Binding protein-interacting protein 120, TIP120, stimulates three classes of eukaryotic transcription via a unique mechanism. Mol Cell Biol (1999) 1.06
A heteromeric transcription factor required for mammalian RNA polymerase II. Nucleic Acids Res (1990) 1.02
Identification and characterization of Elf1, a conserved transcription elongation factor in Saccharomyces cerevisiae. Mol Cell Biol (2005) 1.02
Identification of the Arabidopsis REDUCED DORMANCY 2 gene uncovers a role for the polymerase associated factor 1 complex in seed dormancy. PLoS One (2011) 0.97
Transcription factor IIS cooperates with the E3 ligase UBR5 to ubiquitinate the CDK9 subunit of the positive transcription elongation factor B. J Biol Chem (2010) 0.96
Functional analysis of a stable transcription arrest site in the first intron of the murine adenosine deaminase gene. Mol Cell Biol (1993) 0.96
The block to transcription elongation at the minute virus of mice attenuator is regulated by cellular elongation factors. Mol Cell Biol (1991) 0.95
NTR1 is required for transcription elongation checkpoints at alternative exons in Arabidopsis. EMBO J (2015) 0.86
Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet (2001) 18.55
Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association. Science (1991) 3.84
Extensive unwinding of the plasmid template during staged enzymatic initiation of DNA replication from the origin of the Escherichia coli chromosome. Cell (1986) 3.51
ATP activates dnaA protein in initiating replication of plasmids bearing the origin of the E. coli chromosome. Cell (1987) 3.32
Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J Biol Chem (1996) 2.85
Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats. Kidney Int (2006) 2.57
Tumor promoter, TPA, enhances replication of HTLV-III/LAV. Virology (1986) 2.51
The initiator function of DnaA protein is negatively regulated by the sliding clamp of the E. coli chromosomal replicase. Cell (1998) 2.50
Brain MR in Fukuyama congenital muscular dystrophy. AJNR Am J Neuroradiol (1996) 2.42
Nucleotide sequence of VP4 and VP7 genes of human rotaviruses with subgroup I specificity and long RNA pattern: implication for new G serotype specificity. J Virol (1990) 2.42
Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4. J Virol (1986) 2.40
Interpretation of near-infrared spectroscopy signals: a study with a newly developed perfused rat brain model. J Appl Physiol (1985) (2001) 2.38
Kinesin associates with anterogradely transported membranous organelles in vivo. J Cell Biol (1991) 2.32
TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc Natl Acad Sci U S A (1996) 2.31
Myocardial infarction due to coronary thromboarteritis, following acute febrile mucocutaneous lymph node syndrome (MLNS) in an infant. Pediatrics (1974) 2.00
Thermodynamics of a beta-hairpin structure: evidence for cooperative formation of folding nucleus. J Mol Biol (2000) 2.00
Replication cycle-coordinated change of the adenine nucleotide-bound forms of DnaA protein in Escherichia coli. EMBO J (1999) 1.99
Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling. Exp Cell Res (2000) 1.95
Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol (1999) 1.94
Survey of human rotavirus serotypes in different locales in Japan by enzyme-linked immunosorbent assay with monoclonal antibodies. J Infect Dis (1989) 1.93
Correlation between effects of 24 different cytochalasins on cellular structures and cellular events and those on actin in vitro. J Cell Biol (1982) 1.90
Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis (2007) 1.79
Primary structure of sarcotoxin I, an antibacterial protein induced in the hemolymph of Sarcophaga peregrina (flesh fly) larvae. J Biol Chem (1985) 1.75
Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol (1996) 1.73
Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS (1991) 1.73
Purification of rabbit tumor necrosis factor. FEBS Lett (1985) 1.72
An optical spectrum of the afterglow of a gamma-ray burst at a redshift of z = 6.295. Nature (2006) 1.70
Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro. Antimicrob Agents Chemother (1986) 1.66
Purification of three antibacterial proteins from the culture medium of NIH-Sape-4, an embryonic cell line of Sarcophaga peregrina. J Biol Chem (1988) 1.66
Synthesis of apoferritin in mouse peritoneal macrophages. Characterization of 20 S particles. J Biochem (1976) 1.65
Immunoproteasome assembly and antigen presentation in mice lacking both PA28alpha and PA28beta. EMBO J (2001) 1.65
Simultaneous detection of Staphylococcus aureus and coagulase-negative staphylococci in positive blood cultures by real-time PCR with two fluorescence resonance energy transfer probe sets. J Clin Microbiol (2004) 1.63
Herpes virus type 8-negative primary effusion lymphoma associated with PAX-5 gene rearrangement and hepatitis C virus: a case report and review of the literature. Am J Surg Pathol (1998) 1.59
Recurrent haematuria in childhood. Q J Med (1965) 1.58
Expression of amylase and glucose oxidase in the hypopharyngeal gland with an age-dependent role change of the worker honeybee (Apis mellifera L.). Eur J Biochem (1999) 1.56
In situ visualization of ultraviolet-light-induced DNA damage repair in locally irradiated human fibroblasts. J Invest Dermatol (2001) 1.52
The surgical technique of anterior cervical fusion using bone grafts obtained from cervical vertebral bodies. J Neurosurg (1994) 1.50
Construction of an infectious cDNA clone of Aichi virus (a new member of the family Picornaviridae) and mutational analysis of a stem-loop structure at the 5' end of the genome. J Virol (2001) 1.48
Augmentation of human immunodeficiency virus type 1 gene expression by tumor necrosis factor alpha. AIDS Res Hum Retroviruses (1989) 1.48
Association of p56lck with IL-2 receptor beta chain is critical for the IL-2-induced activation of p56lck. EMBO J (1993) 1.48
Endogenous interleukin 10 prevents apoptosis in macrophages during Salmonella infection. Biochem Biophys Res Commun (1995) 1.47
Cholestasis confers resistance to the rat liver mitochondrial permeability transition. Gastroenterology (1998) 1.46
Molecular heterogeneity in the amino-terminal region of alkaline phosphatase. J Mol Biol (1970) 1.44
Short- and intermediate-term results of (32)P radioactive beta-emitting stent implantation in patients with coronary artery disease: The Milan Dose-Response Study. Circulation (2000) 1.44
Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries. Nat Biotechnol (2000) 1.43
Changing pattern of human group A rotaviruses: emergence of G12 as an important pathogen among children in eastern India. J Clin Virol (2006) 1.42
Inhibition of nuclear export of ribonucleoprotein complexes of influenza virus by leptomycin B. Virus Res (2001) 1.41
[Portal vein embolization for hepatoma with lipiodol-fibrin adhesive mixture]. Nihon Igaku Hoshasen Gakkai Zasshi (1984) 1.41
Properties of human interleukin-2 receptors expressed on non-lymphoid cells by cDNA transfection. Mol Biol Med (1984) 1.41
Maternal immune responses and risk of infant infection with HIV-1 after a short course Zidovudine in a cohort of HIV-1 infected pregnant women in rural Kenya. East Afr Med J (2002) 1.39
Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40. Proc Natl Acad Sci U S A (1999) 1.39
Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replication. J Virol (1989) 1.39
Blood volume measurement at the bedside using ICG pulse spectrophotometry. Anesthesiology (1998) 1.37
Expression of the secretory leukoprotease inhibitor gene in epithelial cells. J Clin Invest (1991) 1.37
Purification, gene cloning, and gene disruption of the transcription elongation factor S-II in Saccharomyces cerevisiae. J Biol Chem (1992) 1.37
IL-15 is a novel growth factor for murine gamma delta T cells induced by Salmonella infection. J Immunol (1996) 1.37
Detection of a human rotavirus with G12 and P[9] specificity in Thailand. J Clin Microbiol (2002) 1.37
Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Invest (1993) 1.37
Presumptive seventh serotype of human rotavirus. Arch Virol (1990) 1.36
Characterization by enzyme-linked immunosorbent assay using subgroup- and serotype-specific monoclonal antibodies of human rotavirus obtained from diarrheic patients in Bangladesh. J Clin Microbiol (1989) 1.36
Analysis of the stimulatory factor of RNA polymerase II in the initiation and elongation complex. J Biol Chem (1984) 1.36
Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibl Haematol (1983) 1.34
Molecular cloning and characterization of cDNA for eukaryotic transcription factor S-II. J Biol Chem (1988) 1.33
Structure-function relationship of yeast S-II in terms of stimulation of RNA polymerase II, arrest relief, and suppression of 6-azauracil sensitivity. J Biol Chem (1995) 1.32
Cloning and sequencing of cDNA of Sarcophaga peregrina humoral lectin induced on injury of the body wall. J Biol Chem (1985) 1.32
Purification and characterization of an antibacterial protein from haemolymph of Sarcophaga peregrina (flesh-fly) larvae. Biochem J (1983) 1.32
Typing of urinary JC virus DNA offers a novel means of tracing human migrations. Proc Natl Acad Sci U S A (1997) 1.30
Soldier caste-specific gene expression in the mandibular glands of Hodotermopsis japonica (Isoptera: termopsidae). Proc Natl Acad Sci U S A (1999) 1.29
CD40 signaling-mediated induction of Bcl-XL, Cdk4, and Cdk6. Implication of their cooperation in selective B cell growth. J Immunol (1995) 1.29
Increased risk of hepatoblastoma among immature children with a lower birth weight. Cancer Res (1998) 1.28
Emergence of novel human group A rotavirus G12 strains in India. J Clin Microbiol (2003) 1.27
Molecular cloning of a cDNA and assignment of the C-terminal of sarcotoxin IA, a potent antibacterial protein of Sarcophaga peregrina. Biochem J (1986) 1.27
New P serotype of group A human rotavirus closely related to that of a porcine rotavirus. J Med Virol (2000) 1.27
The xeroderma pigmentosum group C gene leads to selective repair of cyclobutane pyrimidine dimers rather than 6-4 photoproducts. Proc Natl Acad Sci U S A (2000) 1.25
Ribosome degradation and the degradation products in starved Escherichia coli. I. Comparison of the degradation rate and of the nucleotide pool between Escherichia coli B and Q-13 strains in phosphate deficiency. Biochim Biophys Acta (1970) 1.24
Stabilization of colicin E2 by bovine serum albumin. J Bacteriol (1969) 1.24
Molecular cloning of cDNA for sapecin and unique expression of the sapecin gene during the development of Sarcophaga peregrina. J Biol Chem (1988) 1.24
Phylogenetic analysis of dengue-3 viruses prevalent in Guatemala during 1996-1998. Arch Virol (2001) 1.23
Induction of apoptosis in ischemia-reperfusion model of mouse kidney: possible involvement of Fas. J Am Soc Nephrol (1998) 1.23
Neurofibromatosis type 1 and childhood cancer. Cancer (1993) 1.22
Molecular characterization of a porcine Group A rotavirus strain with G12 genotype specificity. Arch Virol (2006) 1.22
Changes in liver function parameters after occlusion of gastrorenal shunts with balloon-occluded retrograde transvenous obliteration. Am J Gastroenterol (1997) 1.22
Mycotoxin production by Chaetomium spp. and related fungi. Can J Microbiol (1981) 1.21
Mutagenicity of anthraquinones in the Salmonella preincubation test. Mutat Res (1983) 1.21
Primary immunodeficiency syndrome in Japan. I. Overview of a nationwide survey on primary immunodeficiency syndrome. J Clin Immunol (1981) 1.20
Increase in resistance of methicillin-resistant Staphylococcus aureus to beta-lactams caused by mutations conferring resistance to benzalkonium chloride, a disinfectant widely used in hospitals. Antimicrob Agents Chemother (1999) 1.19
Human thymus-lymphoid tissue antigen and its presence in leukaemia and lymphoma. Clin Exp Immunol (1970) 1.19
Epidemiological study of the G serotype distribution of group A rotaviruses in Kenya from 1991 to 1994. J Med Virol (1999) 1.19
Molecular cloning of cDNA for p10, a novel protein that increases in the regenerating legs of Periplaneta americana (American cockroach). Insect Biochem Mol Biol (1998) 1.19
Turnover of ribosomal RNA in a ribonuclease I-less mutant of Escherichia coli, Q-13, which was found to possess polynucleotide phosphorylase. Biochim Biophys Acta (1967) 1.18
Measurement of Sarcophaga peregrina lectin under various physiological conditions by radioimmunoassay. J Biol Chem (1983) 1.18
Foramen magnum decompression with removal of the outer layer of the dura as treatment for syringomyelia occurring with Chiari I malformation. Neurosurgery (1993) 1.18
Transcription stimulation of the Fas-encoding gene by nuclear factor for interleukin-6 expression upon influenza virus infection. J Biol Chem (1995) 1.17
Degradation of ribosomal RNA in a temperature-sensitive Escherichia coli. Arch Biochem Biophys (1967) 1.17
Viral infectious disease and natural products with antiviral activity. Drug Discov Ther (2007) 1.14